Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the Impact of Embolization on Outcomes in Iliopsoas Hematomas: A Multicenter Retrospective Propensity-matched Study.

Academic radiology·2026
Same author

Breast cryoablation: What does the current evidence allow us to say?

Diagnostic and interventional imaging·2026
Same authorSame journal

The Unseen Aneurysm: Can Artificial Intelligence Bridge the Diagnostic Gap in Angiogram-Negative Subarachnoid Hemorrhage?

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
Same author

Occupational radiation exposure and radiation protection practices in interventional radiology and cardiology: A multicenter study in France.

Diagnostic and interventional imaging·2026
Same author

The polystyrene beads sign: a simple MRI marker for the preoperative diagnosis of papillary hypothalamic craniopharyngiomas.

European journal of endocrinology·2026
Same author

A novel anatomical approach to central lymphatics: Cadaveric validation of abdominal and thoracic access for lymphovenous anastomosis.

Current problems in surgery·2026
Same journal

Impact of Canadian Association of Radiologists and Fukuoka Recommendations on MRI Utilization for Surveillance of Incidental Pancreatic Cysts.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
Same journal

Acute Non-Traumatic Urinary Tract Emergencies: The Central Role of CT Imaging and the Emerging Role of Photon-Counting CT.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
Same journal

Reporting Completeness of Diagnostic Accuracy Studies: A Meta-Review of Investigations on Adherence to STARD 2015.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
Same journal

The Heat is On for Canadian Health Care.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
Same journal

Growth, Gaps, and Emerging Priorities in Environmentally Sustainable Medical Imaging.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

427

Interventional Oncology: 2024 Update.

Ruben Geevarghese1, Sylvain Bodard1, Leo Razakamanantsoa2

  • 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes
|March 6, 2024
PubMed
Summary
This summary is machine-generated.

Interventional Oncology (IO) advances cancer care using AI, personalized medicine, and imaging innovations. These technologies enhance tumor detection, treatment precision, and patient outcomes, revolutionizing oncology interventions.

Keywords:
Interventional OncologyInterventional Radiologyimage-guided navigation

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K

Related Experiment Videos

Last Updated: Jul 1, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

427
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K

Area of Science:

  • Interventional Oncology
  • Medical Imaging
  • Artificial Intelligence in Medicine

Background:

  • Interventional Oncology (IO) is a rapidly evolving field transforming cancer treatment.
  • It integrates advanced imaging and innovative minimally invasive procedures.
  • Technological advancements are key to its expanding role in patient care.

Purpose of the Study:

  • To review recent developments and future potential in Interventional Oncology.
  • To highlight the impact of artificial intelligence, personalized medicine, and imaging innovations.
  • To discuss advancements in procedural techniques and patient-centered outcomes.

Main Methods:

  • This study is a narrative review of recent developments in Interventional Oncology.
  • It synthesizes information on AI, personalized medicine, advanced imaging, and procedural innovations.
  • The review also considers training, workforce competence, and patient outcomes.

Main Results:

  • Artificial intelligence (AI) integration accelerates tumor detection, characterization, and treatment strategy refinement.
  • Advanced imaging (fMRI, PET, cone beam CT) and navigation technologies (AR, robotics) enhance procedural precision.
  • Developments in embolization and ablative therapies, alongside genomics, personalize treatment and improve patient-centered outcomes.

Conclusions:

  • Interventional Oncology is significantly enhanced by AI, personalized medicine, and imaging innovations.
  • Technological advancements promise to revolutionize cancer care through improved accuracy and patient outcomes.
  • The synergy between interventional radiologists and new technologies is crucial for advancing cancer treatment.